JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm founded in 2015 and headquartered in San Francisco, California, with additional offices in Santa Monica and Seattle. The firm specializes in growth capital investments within the technology sector, particularly at the intersection of digital technology and neuroscience. JAZZ Venture Partners focuses on companies that leverage advanced brain science to develop innovative technology platforms in areas such as virtual and augmented reality, immersive gaming, artificial intelligence, and closed-loop human-computer systems. The firm aims to enhance human performance across various markets, including health, mind-body wellness, peak mental and physical performance, and accelerated learning. The team comprises experienced investors, entrepreneurs, neuroscientists, and technologists, providing a unique blend of expertise and resources to support exceptional entrepreneurs in building transformative companies.

Stone Connell

Vice President of Finance

Sydney Cureton

Senior Associate

Sujude Dalieh

Senior Associate

Andrew Firlik

General Partner

Sharon Knight

Venture Partner

John Lee

Partner

Zack Lynch

Co-Founder, General Partner

Justin Nuñez

Partner

Meghan Reynolds

Venture Partner

Matt Wan

Senior Associate

Allison Williams

Principal

82 past transactions

Justpoint

Series A in 2025
Justpoint is an artificial intelligence-driven platform that connects individuals seeking personal injury litigation with appropriate attorneys and resources. By employing predictive analytics, Justpoint enhances transparency and efficiency in the process of identifying qualified litigators, moving away from traditional advertising methods. The platform assists law firms by managing back-office tasks and streamlining the discovery process, allowing attorneys to quickly assess the merits of claims and achieve optimal outcomes. With a network of over 1,000 law firms and access to more than 300,000 historical claims across 33 states, Justpoint aims to improve access to justice while facilitating better matches between plaintiffs and legal representation.

KLOWEN Braces

Series B in 2024
KLOWEN Braces, Inc. is a company based in Fort Collins, Colorado, that specializes in developing custom braces systems for orthodontists and their patients. Founded in 2019, KLOWEN Braces utilizes a software platform to create ideally shaped brackets for each tooth, enhancing the effectiveness and comfort of the orthodontic treatment. The company offers a range of products, including prefabricated, modular brackets, as well as brackets with hooks, bundles, tubes, and wires, available for online purchase. By combining innovative technology with quality materials, KLOWEN aims to provide a faster and more comfortable alternative to traditional braces.

Pinpoint Predictive

Series A in 2024
Pinpoint Predictive is a technology company that provides property and casualty insurers with loss predictions and risk scores based solely on a customer's name and address. Its platform offers actuarial predictions related to claims frequency, severity, and loss costs, allowing insurers to enhance risk selection early in the customer journey. Additionally, the platform supplies risk scores for various purposes, including special investigation unit referrals, litigation, early cancellation, and premium leakage. By facilitating better tracking of consumers, Pinpoint Predictive enables insurance companies to tailor their product offerings more effectively.

Enveda Biosciences

Series B in 2024
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Bonito Biosciences

Seed Round in 2024
Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.

Transcripta Bio

Venture Round in 2024
Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance.

Reken

Seed Round in 2024
Reken is an AI and cybersecurity company established in 2024 and headquartered in San Francisco, California. The firm focuses on developing an innovative platform designed to address threats posed by generative artificial intelligence, including deepfake social engineering and automated fraud. Reken's approach combines a layered defense strategy with elements of zero trust, allowing for comprehensive technological analysis of content to help users effectively identify malicious activities. By creating a new category of AI products, Reken aims to enhance security measures against evolving AI-enabled threats.

Tomato.ai

Seed Round in 2023
Tomato.ai specializes in artificial intelligence-based voice clarity software that enhances the intelligibility of offshore agents during calls. By softening accents and implementing advanced noise cancellation solutions, the company aims to improve communication between agents and clients, fostering trust and understanding. This technology not only facilitates more effective conversations but also enables businesses to hire a larger pool of offshore agents, ultimately leading to increased savings and sales while reducing agent churn. Through its innovative approach, Tomato.ai seeks to enhance the overall efficiency of agent interactions.

HerMD

Series A in 2023
HERmd is a healthcare provider specializing in comprehensive health, beauty, and wellness services tailored specifically for women. Founded by Somi Javaid in 2019 and headquartered in Cincinnati, Ohio, the company offers a broad range of services designed to empower women and address their unique needs. These services include gynecology, menopause management, sexual medicine, obesity counseling, labiaplasty, and various medical aesthetic treatments such as clinical facials and chemical peels. HERmd aims to create a safe and trusted environment for women to discuss and manage their health and well-being, regardless of how personal the issues may be.

Robust.AI

Series A in 2023
Robust.AI, founded by Anthony Jules in 2019 and based in San Carlos, California, develops advanced solutions that combine artificial intelligence, robotics, and human-centered design. The company has introduced its software suite, Grace, and a concept for a hardware product, Carter, aimed at enhancing interaction between humans and robots. These innovations target the warehousing industry, where a significant majority of operations remain unautomated, exacerbated by ongoing labor shortages in the global supply chain. Robust.AI's cognitive platform focuses on creating collaborative mobile robots that are context-aware, safe, and easy to implement, aiming to make robotics solutions more accessible across various sectors. By emphasizing common-sense AI and hybrid technology, the company seeks to address the challenges of robotics deployment and improve operational efficiency.

Zus Health

Series A in 2023
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.

Cadence Neuroscience

Venture Round in 2023
Cadence Neuroscience, Inc. is an early-stage company focused on developing innovative medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company is leveraging core technology developed at the Mayo Clinic, which is currently under clinical evaluation. Cadence's implantable devices are designed to detect specific brain signals and deliver tailored electrical stimulation to modify neural circuit activity. This approach aims to enhance seizure control and improve treatment methods, offering medical practitioners a customizable solution for managing neurological conditions.

Revelata

Pre Seed Round in 2023
Revelata develops an artificial intelligence platform for extracting data from complex financial documents. It's first product, deepKPI, automatically surfaces hard-to-get KPI time series that are buried within billions of pages of SEC filings. The company was founded in 2020 and is headquartered in Palo Alto, California.

Colossal Laboratories & Biosciences

Series B in 2023
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

Enveda Biosciences

Series B in 2022
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Form Bio

Series A in 2022
Form Bio is a biotechnology company that addresses data, computational, and technical challenges in the life sciences sector. It offers a comprehensive platform designed to empower scientific discovery by providing end-to-end integration of the research process. The platform features a range of tools including workflows, data management, collaboration, data visualization, and a workflow catalog, catering to various stakeholders such as lab directors, biotech firms, pharmaceutical companies, and academic institutions. By combining intuitive software applications with an open and adaptable collaborative environment, Form Bio enables scientists to efficiently leverage the growing abundance of data and computing power in their research efforts.

Form Bio

Series A in 2022
Form Bio is a biotechnology company that addresses data, computational, and technical challenges in the life sciences sector. It offers a comprehensive platform designed to empower scientific discovery by providing end-to-end integration of the research process. The platform features a range of tools including workflows, data management, collaboration, data visualization, and a workflow catalog, catering to various stakeholders such as lab directors, biotech firms, pharmaceutical companies, and academic institutions. By combining intuitive software applications with an open and adaptable collaborative environment, Form Bio enables scientists to efficiently leverage the growing abundance of data and computing power in their research efforts.

Foresight Mental Health

Series C in 2022
Foresight Mental Health is a technology-driven provider of psychiatry and therapy services, operating a network of clinics dedicated to mental health and wellness. The company employs a diverse team that includes psychiatrists, therapists, and psychiatric nurse practitioners who deliver care directly to patients. Foresight enhances its treatment offerings through innovative technology developed in collaboration with software and biomedical engineers, aimed at transforming the mental healthcare experience. By utilizing comprehensive patient profiles and a database of scientific research, the company conducts detailed analyses that include genetic profiles and assessments of brain-chemical balance. This holistic approach enables Foresight to offer tailored treatments, ultimately helping patients achieve improved mental health and overall well-being.

JobGet

Series B in 2022
JobGet Inc. is a mobile hiring application and job search platform based in Boston, Massachusetts, established in 2017. It serves as a marketplace connecting employers and job seekers, facilitating direct communication through messaging, scheduling meetings, and conducting video interviews. The platform is particularly focused on the retail and hospitality industries, significantly accelerating the job search process by reducing the timeline from weeks to mere minutes. JobGet has gained recognition as a top-rated application on both iOS and Android, assisting thousands of job seekers in engaging with prominent employers.

Oma Fertility

Venture Round in 2022
Oma Fertility is a comprehensive fertility clinic that provides a range of fertility care services, including in-vitro fertilization (IVF), egg freezing, embryo transfer, egg donation, sperm donation, and gestational surrogacy. The clinic utilizes advanced technologies, including artificial intelligence, to enhance the selection process of sperm cells for IVF through its proprietary AI microscope, Oma Sperm InSight. By integrating top lab design and technology with personalized care, Oma Fertility aims to make fertility treatments more accessible and affordable for a diverse population. The clinic also collaborates with external partners, such as surrogate agencies and egg and sperm banks, to facilitate a seamless experience for individuals and couples seeking fertility assistance.

Swing Therapeutics

Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

KLOWEN Braces

Series A in 2022
KLOWEN Braces, Inc. is a company based in Fort Collins, Colorado, that specializes in developing custom braces systems for orthodontists and their patients. Founded in 2019, KLOWEN Braces utilizes a software platform to create ideally shaped brackets for each tooth, enhancing the effectiveness and comfort of the orthodontic treatment. The company offers a range of products, including prefabricated, modular brackets, as well as brackets with hooks, bundles, tubes, and wires, available for online purchase. By combining innovative technology with quality materials, KLOWEN aims to provide a faster and more comfortable alternative to traditional braces.

Colossal Laboratories & Biosciences

Series A in 2022
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

HerMD

Series A in 2022
HERmd is a healthcare provider specializing in comprehensive health, beauty, and wellness services tailored specifically for women. Founded by Somi Javaid in 2019 and headquartered in Cincinnati, Ohio, the company offers a broad range of services designed to empower women and address their unique needs. These services include gynecology, menopause management, sexual medicine, obesity counseling, labiaplasty, and various medical aesthetic treatments such as clinical facials and chemical peels. HERmd aims to create a safe and trusted environment for women to discuss and manage their health and well-being, regardless of how personal the issues may be.

Augment AI

Seed Round in 2022
Augment AI specializes in developing innovative artificial intelligence technology aimed at enhancing productivity and simplifying daily tasks. Its context-aware AI learns individual preferences and priorities, allowing it to become a personalized extension of its users. This technology features interactive assistants known as Augments, which help users by remembering important information, anticipating needs, and facilitating task completion alongside familiar applications. By streamlining processes such as note-taking and action item management, Augment AI empowers employees to work more efficiently and effectively, ultimately improving overall productivity.

Yumi

Series B in 2021
Yumi is a company that focuses on providing science-based meal delivery services for young children, aiming to help parents understand their children's nutritional needs. The company produces fresh, nutrient-dense, and low-sugar baby food products that cater to various age groups, ensuring that children receive adequate nutrition during their critical early years. In addition to baby food, Yumi offers vitamins designed to support brain development, making it a comprehensive resource for parents seeking healthy options for their children’s diets. Through its convenient meal delivery program, Yumi stands out as a leading choice for those prioritizing nutrition in early childhood.

Sounding Board

Series B in 2021
Sounding Board is a technology company that specializes in leadership development. It offers a platform that provides personalized coaching for leaders and managers, connecting them with qualified coaches via phone, video, and chat. The platform creates tailored development plans, automates administration tasks, and offers data visualization tools to track progress and measure impact. Sounding Board serves global enterprises across 11 countries, with a strong focus on user experience and high-quality coaching. It was founded in 2016 and is headquartered in Foster City, California.

AppliedVR

Series B in 2021
AppliedVR, Inc. is a Los Angeles-based company founded in 2013 that specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, particularly for pain and anxiety management. The company’s flagship product, EaseVRx, is a VR-based prescription therapeutic that has received Breakthrough Device Designation from the FDA. By integrating principles of cognitive behavioral therapy and mindfulness, EaseVRx provides a comprehensive approach to managing chronic pain, addressing biological, psychological, and social factors. This platform allows patients to self-administer treatment at home, offering flexibility and promoting better quality of life. AppliedVR has established strategic partnerships with prominent healthcare institutions, including Cedars-Sinai and Children's Hospital Los Angeles, furthering its mission to empower patients in their pain management journey.

Magnus Medical

Series A in 2021
Magnus Medical focuses on developing a closed-loop neuromodulation technology aimed at treating intractable neurological and psychiatric disorders. This innovative brain stimulation method has shown the potential for rapid and significant results by producing identifiable changes in brain networks. The technology enables individuals to manage their symptoms effectively and aims to restore and sustain mental health, offering a new approach for those struggling with persistent mental health challenges.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile and web-based platform. The company focuses on the healthcare sector, offering a certified nursing assistant (CNA) training program and facilitating the recruitment, training, and placement of individuals for entry-level healthcare positions, including community health workers, home health aides, and medical assistants. NextStep aims to enable individuals to quickly and affordably re-skill themselves while assisting employers in the healthcare industry in finding qualified personnel.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company based in San Francisco, California, founded in 2018. The company focuses on enhancing mental health care for cancer patients through its innovative digital therapeutics platform. By collaborating with medical researchers and patient advocacy organizations, Blue Note Therapeutics delivers evidence-based therapeutic interventions via mobile devices. This approach allows patients to access effective treatments designed to prevent, manage, and address their medical conditions, enabling healthcare providers to utilize these digital solutions as primary or supplementary therapies for serious illnesses.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of treatments for rare diseases. The company has created a platform that produces regulatory-ready evidence to support rare disease research and drug development. This platform operates as a two-sided network where patients with rare diseases and advocacy groups contribute valuable information, while life science companies utilize this data to identify new drug candidates. Additionally, AllStripes offers a patient application that allows individuals to engage in treatment research online and leverage their own medical data, fostering a collaborative environment aimed at advancing medical research for rare conditions.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Swing Therapeutics

Seed Round in 2021
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Intuition

Series A in 2021
Intuition is an AI-powered platform that offers employee engagement solutions.

Thrive Global

Series C in 2021
Thrive Global is a behavior change technology company founded by Arianna Huffington in 2016, with headquarters in New York City and additional offices in San Francisco, Athens, Bucharest, Dublin, and Melbourne. The company aims to transform workplace culture and personal well-being by providing a platform that combines data, storytelling, and actionable strategies known as Microsteps. Thrive Global offers science-based solutions designed to reduce stress and burnout, promoting improved mental and physical health for individuals, corporations, and communities. The company's mission focuses on fostering a healthier relationship with technology and enhancing overall performance and purpose, ultimately challenging the notion that burnout is an inevitable part of success.

Zeitworks

Venture Round in 2021
Zeitworks is a developer of a machine learning-based SaaS platform focused on enhancing business processes. The platform aims to discover, analyze, and improve operational workflows without disrupting users or needing system integrations. By employing proprietary technology, Zeitworks captures and measures the execution of business processes step-by-step, following the paths workers take during their regular activities. This approach allows clients to identify opportunities for efficiency gains and improvements in customer experience. Currently, the platform is available to select pilot customers as the company continues to refine its offering.

Colossal Laboratories & Biosciences

Seed Round in 2021
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.

AppliedVR

Series A in 2021
AppliedVR, Inc. is a Los Angeles-based company founded in 2013 that specializes in virtual reality solutions aimed at enhancing patient experiences in healthcare, particularly for pain and anxiety management. The company’s flagship product, EaseVRx, is a VR-based prescription therapeutic that has received Breakthrough Device Designation from the FDA. By integrating principles of cognitive behavioral therapy and mindfulness, EaseVRx provides a comprehensive approach to managing chronic pain, addressing biological, psychological, and social factors. This platform allows patients to self-administer treatment at home, offering flexibility and promoting better quality of life. AppliedVR has established strategic partnerships with prominent healthcare institutions, including Cedars-Sinai and Children's Hospital Los Angeles, furthering its mission to empower patients in their pain management journey.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company based in San Francisco, California, founded in 2018. The company focuses on enhancing mental health care for cancer patients through its innovative digital therapeutics platform. By collaborating with medical researchers and patient advocacy organizations, Blue Note Therapeutics delivers evidence-based therapeutic interventions via mobile devices. This approach allows patients to access effective treatments designed to prevent, manage, and address their medical conditions, enabling healthcare providers to utilize these digital solutions as primary or supplementary therapies for serious illnesses.

Outside

Series B in 2021
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Arrive Health

Series B in 2021
Arrive Health, founded in 2013 and based in Denver, Colorado, focuses on enhancing access to affordable, quality healthcare by providing precise, patient-specific cost and coverage information. The company develops integrated technologies that streamline workflows within health systems, facilitating conversations about affordability and access. By connecting a network of payers, pharmacy benefit managers, IT vendors, and other tools, Arrive Health alerts providers and care teams to coverage restrictions, lower-cost alternatives, and location-based options. This enables healthcare professionals to make well-informed decisions, ultimately reducing barriers throughout the care continuum.

NextStep

Venture Round in 2021
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile and web-based platform. The company focuses on the healthcare sector, offering a certified nursing assistant (CNA) training program and facilitating the recruitment, training, and placement of individuals for entry-level healthcare positions, including community health workers, home health aides, and medical assistants. NextStep aims to enable individuals to quickly and affordably re-skill themselves while assisting employers in the healthcare industry in finding qualified personnel.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Genesis Therapeutics

Series A in 2020
Genesis Therapeutics Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019, the company harnesses a proprietary artificial intelligence platform that employs advanced deep neural networks and biophysical simulation techniques to enhance drug discovery and molecular design. By combining these innovative technologies with a scalable computing infrastructure, Genesis Therapeutics aims to improve the efficiency and accuracy of molecular research. This approach not only facilitates the generation and analysis of novel drug candidates but also holds the potential to significantly advance clinical outcomes in the medical community.

Robust.AI

Series A in 2020
Robust.AI, founded by Anthony Jules in 2019 and based in San Carlos, California, develops advanced solutions that combine artificial intelligence, robotics, and human-centered design. The company has introduced its software suite, Grace, and a concept for a hardware product, Carter, aimed at enhancing interaction between humans and robots. These innovations target the warehousing industry, where a significant majority of operations remain unautomated, exacerbated by ongoing labor shortages in the global supply chain. Robust.AI's cognitive platform focuses on creating collaborative mobile robots that are context-aware, safe, and easy to implement, aiming to make robotics solutions more accessible across various sectors. By emphasizing common-sense AI and hybrid technology, the company seeks to address the challenges of robotics deployment and improve operational efficiency.

Freeletics

Series B in 2020
Freeletics GmbH is a digital fitness company headquartered in Munich, Germany, founded in 2013. It specializes in developing a fitness application that provides personalized, AI-driven coaching to enhance both physical fitness and mental strength. The application offers tools for workout routines, nutrition coaching, and health assessments, enabling users to engage in training without the need for equipment or a gym. By focusing on individual goals and promoting elements such as willpower and confidence, Freeletics aims to help users achieve their fullest potential in both fitness and lifestyle.

Outside

Series A in 2020
Outside operator of a digital media company planned to produce a collection of an active lifestyle and sports material. The company publishes lifestyle content such as storytelling, meal plans, gear reviews, online courses, films, TV series, discounted event access, magazines, and more across television, mobile, desktop, and print outlets from a variety of brands, allowing people to access a reliable website for endurance sports information.

Zeitworks

Seed Round in 2020
Zeitworks is a developer of a machine learning-based SaaS platform focused on enhancing business processes. The platform aims to discover, analyze, and improve operational workflows without disrupting users or needing system integrations. By employing proprietary technology, Zeitworks captures and measures the execution of business processes step-by-step, following the paths workers take during their regular activities. This approach allows clients to identify opportunities for efficiency gains and improvements in customer experience. Currently, the platform is available to select pilot customers as the company continues to refine its offering.

The Meta

Series A in 2020
The Meta is an e-sports training platform aimed at the extensive community of gamers engaged in first-person shooters. By integrating sports performance science, game development, and machine learning, the platform enhances gamers' skills, enabling them to improve their performance and achieve competitive success. The company's software is designed to guide users on their journey toward mastery, making it a valuable resource for those seeking to elevate their gaming abilities and ascend the ranks in competitive play.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

NextStep

Venture Round in 2020
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile and web-based platform. The company focuses on the healthcare sector, offering a certified nursing assistant (CNA) training program and facilitating the recruitment, training, and placement of individuals for entry-level healthcare positions, including community health workers, home health aides, and medical assistants. NextStep aims to enable individuals to quickly and affordably re-skill themselves while assisting employers in the healthcare industry in finding qualified personnel.

Mahana Therapeutics

Seed Round in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

Cadence Neuroscience

Series A in 2019
Cadence Neuroscience, Inc. is an early-stage company focused on developing innovative medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company is leveraging core technology developed at the Mayo Clinic, which is currently under clinical evaluation. Cadence's implantable devices are designed to detect specific brain signals and deliver tailored electrical stimulation to modify neural circuit activity. This approach aims to enhance seizure control and improve treatment methods, offering medical practitioners a customizable solution for managing neurological conditions.

NextStep

Series A in 2019
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile and web-based platform. The company focuses on the healthcare sector, offering a certified nursing assistant (CNA) training program and facilitating the recruitment, training, and placement of individuals for entry-level healthcare positions, including community health workers, home health aides, and medical assistants. NextStep aims to enable individuals to quickly and affordably re-skill themselves while assisting employers in the healthcare industry in finding qualified personnel.

Arrive Health

Series A in 2019
Arrive Health, founded in 2013 and based in Denver, Colorado, focuses on enhancing access to affordable, quality healthcare by providing precise, patient-specific cost and coverage information. The company develops integrated technologies that streamline workflows within health systems, facilitating conversations about affordability and access. By connecting a network of payers, pharmacy benefit managers, IT vendors, and other tools, Arrive Health alerts providers and care teams to coverage restrictions, lower-cost alternatives, and location-based options. This enables healthcare professionals to make well-informed decisions, ultimately reducing barriers throughout the care continuum.

Wade & Wendy

Series A in 2019
Wade & Wendy, Inc. is a New York-based company that has developed an innovative software platform aimed at enhancing the hiring process through the use of artificial intelligence. Founded in 2015 by Josh Brandoff, Adrian von der Osten, and Drew Austin, the company offers two main chatbots: Wendy, which assists employers by screening applicants and providing recommendations on career websites, and Wade, which supports job seekers by recording their data and helping them find suitable job opportunities. By leveraging machine intelligence and big data, Wade & Wendy strives to create a more engaging and human-centric hiring experience, facilitating better connections between job seekers and hiring teams.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

AI Redefined

Seed Round in 2018
AI Redefined is a software company focused on machine learning research and applications, aiming to enhance the collaboration between humans and artificial intelligence. Its primary mission is to create a safe digital environment where both AIs and people can learn from each other continuously. The company's flagship product, Cogment, is a high-performance, open-source framework designed for multi-agent training, facilitating real-time interactions between AIs and humans. This platform provides essential tools and infrastructure, including operator AI apprentices and adaptive learning capabilities, which support ongoing live training. By fostering effective human-AI collaboration, AI Redefined enables clients to rapidly and seamlessly integrate AI technology into their operations.

Freeletics

Series A in 2018
Freeletics GmbH is a digital fitness company headquartered in Munich, Germany, founded in 2013. It specializes in developing a fitness application that provides personalized, AI-driven coaching to enhance both physical fitness and mental strength. The application offers tools for workout routines, nutrition coaching, and health assessments, enabling users to engage in training without the need for equipment or a gym. By focusing on individual goals and promoting elements such as willpower and confidence, Freeletics aims to help users achieve their fullest potential in both fitness and lifestyle.

NextStep

Seed Round in 2018
NextStep is an information technology company based in Seattle, Washington, founded in 2018. It specializes in providing training and job placement services through a mobile and web-based platform. The company focuses on the healthcare sector, offering a certified nursing assistant (CNA) training program and facilitating the recruitment, training, and placement of individuals for entry-level healthcare positions, including community health workers, home health aides, and medical assistants. NextStep aims to enable individuals to quickly and affordably re-skill themselves while assisting employers in the healthcare industry in finding qualified personnel.

Perceptive Automata

Series A in 2018
Perceptive Automata, Inc. specializes in developing machine learning and computer vision solutions focused on human behavior prediction for automated vehicles. Founded in 2014 and based in Somerville, Massachusetts, the company addresses critical challenges in the safe deployment of highly automated and fully autonomous vehicles, particularly in urban settings. Its technology enables these vehicles to anticipate the actions of pedestrians, cyclists, and other drivers, allowing for safe navigation in human-dominated environments. By employing advanced AI inference models, Perceptive Automata enhances the driving experience, facilitating smoother and more natural interactions between autonomous vehicles and their surroundings. The company collaborates with original equipment manufacturers (OEMs), suppliers, and technology firms in the development of advanced driver-assistance systems (ADAS) and autonomous driving technologies, leveraging expertise from leading institutions such as Harvard, MIT, and Stanford.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Freeletics

Venture Round in 2018
Freeletics GmbH is a digital fitness company headquartered in Munich, Germany, founded in 2013. It specializes in developing a fitness application that provides personalized, AI-driven coaching to enhance both physical fitness and mental strength. The application offers tools for workout routines, nutrition coaching, and health assessments, enabling users to engage in training without the need for equipment or a gym. By focusing on individual goals and promoting elements such as willpower and confidence, Freeletics aims to help users achieve their fullest potential in both fitness and lifestyle.

Embodied

Series A in 2018
Embodied, Inc. is a robotics company based in Pasadena, California, specializing in the development of personal companion robots aimed at enhancing care and wellness. Founded in 2016 and formerly known as CareBots, Inc., the company has created Moxie, an interactive robot designed for children that promotes social, emotional, and cognitive development through play-based learning. Drawing on over 14 years of research in socially assistive robotics from the University of Southern California and extensive experience in consumer robotics, Embodied combines advanced artificial intelligence with engaging storytelling and animation techniques. The company's mission is to improve the quality of life for individuals and families by providing life-like, interactive robots that serve as motivators, coaches, and companions, empowering users to improve their own well-being.

Wisdo Health

Convertible Note in 2018
Mediscope is an innovative platform focused on addressing the challenges of social isolation and its detrimental effects on mental and physical health. By leveraging evidence-based peer support and benefits navigation, Mediscope aims to enhance health outcomes and reduce medical costs. The platform facilitates meaningful connections among users, allowing them to share experiences and gain insights from individuals who have faced similar challenges. Through its AI-powered features, Mediscope empowers individuals to navigate their health journeys more effectively, promoting engagement and community support to combat loneliness and foster well-being.

Thrive Global

Series B in 2018
Thrive Global is a behavior change technology company founded by Arianna Huffington in 2016, with headquarters in New York City and additional offices in San Francisco, Athens, Bucharest, Dublin, and Melbourne. The company aims to transform workplace culture and personal well-being by providing a platform that combines data, storytelling, and actionable strategies known as Microsteps. Thrive Global offers science-based solutions designed to reduce stress and burnout, promoting improved mental and physical health for individuals, corporations, and communities. The company's mission focuses on fostering a healthier relationship with technology and enhancing overall performance and purpose, ultimately challenging the notion that burnout is an inevitable part of success.

Akili Interactive

Series C in 2018
Akili Interactive is a digital medicine company focused on developing innovative cognitive treatments using technology. The company has a diverse pipeline of programs designed to address cognitive deficiencies and alleviate symptoms associated with various medical conditions. These include attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), and several inflammatory diseases. By leveraging engaging digital platforms, Akili aims to improve patient outcomes in the fields of neurology and psychiatry through its unique therapeutic approaches.

Woebot Health

Series A in 2018
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Halo Neuro

Series B in 2018
Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training. The company was incorporated in 2013 and is based in San Francisco, CA.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Level Ex

Series A in 2017
Level Ex, Inc. is a Chicago-based company that develops virtual surgery mobile applications aimed at enhancing the skills of physicians through immersive training experiences. The company offers a platform called Virtual Technique Guides, which leverages cloud gaming technology to facilitate interactive surgical training. This platform allows surgeons to perform virtual procedures alongside medical device sales representatives in a web conferencing environment. Additionally, Level Ex has developed Airway EX, an app tailored for mastering critical endoscopic and interventional airway procedures. This application addresses various medical scenarios, including managing obstructing tumors, vocal cord injuries, and complex intubations in both adult and pediatric patients. Founded in 2015, Level Ex combines video game technology and cognitive neuroscience to provide physicians with tools to navigate rare medical cases, new medical devices, and evolving drug therapies.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Augment CXM

Seed Round in 2017
Augment CXM is a developer of a customer experience management platform that enhances the efficiency of customer service agents through advanced artificial intelligence tools. Utilizing a patented semantic neural network, the platform analyzes digital and voice communications in real-time, providing actionable insights that help improve key performance indicators. This innovative approach has proven effective for a diverse clientele, including some of the world's most recognized brands, leading to significant improvements such as a 30% increase in agent efficiency, a 44% rise in sales conversion rates, and a 40% boost in customer satisfaction. By focusing on the dual goals of enhancing customer service efficiency and overall customer experience, Augment CXM is establishing a new standard in the industry.

Aira

Series B in 2017
Aira is dedicated to enhancing accessibility for individuals who are blind or have low vision. The company offers remote visual interpretation services through an app that connects users with highly trained Visual Interpreters. By streaming live video from the user's smartphone camera, these interpreters assist with a variety of tasks, including navigation and face recognition, enabling users to engage more fully in daily activities. Additionally, Aira has developed a wearable assistive product that utilizes smart glasses and an augmented reality dashboard, allowing certified agents to see what the user sees in real-time. This combination of technology and human support empowers visually impaired individuals to navigate their environments with greater independence and confidence.

Two Bit Circus

Series B in 2017
Two Bit Circus, Inc. is an entertainment company based in Los Angeles, California, that specializes in creating and installing micro-amusement parks. These parks, which are approximately one acre in size, combine cutting-edge interactive technology with the traditional elements of circus and carnival. The company's offerings include a wide range of immersive experiences such as games, interactive amusement, stage shows, and aerial performances, alongside food and merchandise like T-shirts and stickers. Two Bit Circus also provides a Park as a Platform program that allows game developers to create location-based entertainment. Committed to community engagement, the company supports the Two Bit Circus Foundation, a nonprofit organization focused on promoting STEAM education and environmental stewardship through hands-on learning opportunities for youth. Founded in 2012, Two Bit Circus aims to redefine recreational experiences by fostering social interactions and creativity in a vibrant, engaging environment.

Halo Neuro

Series A in 2016
Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training. The company was incorporated in 2013 and is based in San Francisco, CA.

Pear Therapeutics

Series A in 2016
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Akili Interactive

Series B in 2016
Akili Interactive is a digital medicine company focused on developing innovative cognitive treatments using technology. The company has a diverse pipeline of programs designed to address cognitive deficiencies and alleviate symptoms associated with various medical conditions. These include attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), and several inflammatory diseases. By leveraging engaging digital platforms, Akili aims to improve patient outcomes in the fields of neurology and psychiatry through its unique therapeutic approaches.

Level Ex

Seed Round in 2016
Level Ex, Inc. is a Chicago-based company that develops virtual surgery mobile applications aimed at enhancing the skills of physicians through immersive training experiences. The company offers a platform called Virtual Technique Guides, which leverages cloud gaming technology to facilitate interactive surgical training. This platform allows surgeons to perform virtual procedures alongside medical device sales representatives in a web conferencing environment. Additionally, Level Ex has developed Airway EX, an app tailored for mastering critical endoscopic and interventional airway procedures. This application addresses various medical scenarios, including managing obstructing tumors, vocal cord injuries, and complex intubations in both adult and pediatric patients. Founded in 2015, Level Ex combines video game technology and cognitive neuroscience to provide physicians with tools to navigate rare medical cases, new medical devices, and evolving drug therapies.

Eyefluence

Series B in 2015
Eyefluence, Inc. specializes in developing eye-interaction technology for controlling augmented reality (AR), virtual reality (VR), and mixed reality (MR) head-mounted displays (HMDs) using eye movements. Founded in 2013 and based in Reno, Nevada, the company integrates its technology with HMDs to enhance user interaction through natural eye tracking and control, leveraging a deep understanding of eye biomechanics and the eye-brain connection. Eyefluence holds a substantial intellectual property portfolio, with over 30 patents granted or pending, and collaborates with both emerging startups and established Fortune 100 companies to promote the adoption of smart glasses for various applications, including enterprise, industrial, government, and consumer sectors. The multidisciplinary team is led by experienced entrepreneurs and focuses on overcoming technical challenges to create seamless user experiences in AR, VR, and MR environments. As of late 2016, Eyefluence operates as a subsidiary of Google.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.